Discharge to Assess Community Beds

The procurement contact named on the official notice.

NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board have awarded a time limited contract in accordance with Regulation 14 of the Health Care Services (Provider Selection Regime) Regulations 2023, for the provision of 12 P3 Pathway Discharge to Assess Beds to Cedar Care Homes Ltd under urgent circumstances.

These beds will be delivered at Oakhill Mansions operated by Cedar Care Homes Ltd.

The system is facing an immediate and unplanned capacity shortfall from April 2026 and creates a direct and imminent risk to patient safety and system flow, which could not reasonably have been fully mitigated through earlier procurement action given the reliance on transformation programmes that were, at the time, expected to reduce demand within the existing contracted capacity.

Pathway 3 (P3) beds form part of the Discharge to Assess (D2A) model and are intended for individuals who are medically optimised for discharge from acute hospital settings but have complex, high-level care needs that cannot be safely met in their own home environment at the point of discharge.

P3 beds are typically provided within registered residential or nursing care home settings and deliver 24-hour care and support, including access to nursing provision where required.

The service is VAT‑exempt, and all contract values stated are excluding VAT